Phenylbutyrate and β-cell function: contribution of histone deacetylases and ER stress inhibition

Sabbir Khan1, Sandeep K Komarya1, Gopabandhu Jena1

  • 1Facility for Risk Assessment & Intervention Studies, Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education & Research, Sector-67, SAS Nagar, Punjab-160062, India.

Epigenomics
|May 5, 2017
PubMed

Insights

Phenylbutyrate (PBA), an FDA-approved drug, shows promise for treating diabetes by reducing endoplasmic reticulum (ER) stress and inhibiting histone deacetylases (HDACs). This approach may improve beta-cell function and insulin resistance, offering a new therapeutic avenue.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Molecular Biology

Background:

  • Global diabetes incidence is rising, driven by genetic and epigenetic factors.
  • Endoplasmic reticulum (ER) stress and histone deacetylases (HDACs) play critical roles in beta-cell dysfunction and insulin resistance.
  • Phenylbutyrate (PBA) is an FDA-approved drug known to inhibit HDACs and reduce ER stress.

Purpose of the Study:

  • To review the potential of Phenylbutyrate (PBA) as a therapeutic agent for diabetes.
  • To explore PBA's mechanisms of action, including ER stress inhibition and HDAC inhibition.
  • To evaluate PBA's impact on beta-cell function and insulin resistance.

Main Methods:

  • Review of existing scientific literature on PBA, ER stress, HDACs, and diabetes.
  • Analysis of studies investigating PBA's effects on cellular pathways related to diabetes.
  • Synthesis of evidence regarding PBA's influence on beta-cell function and insulin resistance.

Main Results:

  • Chronic ER stress contributes to beta-cell apoptosis and failure.
  • HDAC inhibition by PBA can modulate key biochemical pathways.
  • PBA demonstrates potential to improve beta-cell function and insulin sensitivity.

Conclusions:

  • PBA's ability to inhibit ER stress and HDACs suggests a promising therapeutic strategy for diabetes.
  • Further research into PBA's efficacy and safety for diabetes treatment is warranted.
  • Targeting ER stress and HDACs with PBA may offer a novel approach to managing diabetes.

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.8K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.7K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.2K
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.6K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
787
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
7.6K